Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network

Abroad (travel likely)Recruiting

Conditions

Chronic Myeloid Leukemia (CML)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione IRCCS San Gerardo dei Tintori, Monza, MB, Italy
Contact: Study coordinator (Carlo Gambacorti-Passerini) · carlo.gambacorti@unimib.it · +39 0392339553
Contact: Principal Investigator (Carlo Gambacorti-Passerini)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Ghent, Belgium · Paris, France

Second STOP After Pioglitazone Priming in CML Patients

Chronic Myeloid Leukemia (CML)

Abroad (travel likely)RecruitingPHASE2

Le Chesnay, France · Le Kremlin-Bicêtre, France

Registry of Older Patients With Cancer

Chronic Myeloproliferative Disorders · Cognitive/Functional Effects · Leukemia

Abroad (travel likely)Recruiting

Boone, United States · Chapel Hill, United States

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Houston, United States